Valmet Oyj's press release, July 7, 2025, at 11:00 a.m. EEST
ESPOO, Finland, July 7, 2025 /PRNewswire/ -- Valmet has received an order from Kraftringen Energi for...
Baltimore, MD, July 05, 2025 (GLOBE NEWSWIRE) -- As President Trump prepares to introduce what insiders are calling the most ambitious legislative package of his second term—a multi-trillion-dollar infrastructure, energy, and defense initiative—one expert says America may already have the financial foundation to pay for ventures like it, buried beneath its own soil.
Washington, D.C., July 04, 2025 (GLOBE NEWSWIRE) -- As political debate intensifies over the cost and scale of President Trump’s sweeping legislative proposal—referred to by insiders as the “Big Beautiful Bill”—a released presentation by Jim Rickards suggests the U.S. government may already control the means to fund the majority of programs just like this internally.
Washington, D.C., July 03, 2025 (GLOBE NEWSWIRE) -- As President Trump prepares to unveil what insiders are calling a “Big Beautiful Bill” to reshape America’s industrial and energy backbone, a resurfaced presentation from former Pentagon and White House advisor Jim Rickards points to a little-known domestic asset that could provide the financial foundation for agendas just like this one—without new taxes, debt ceilings, or foreign loans.
In this 2025 strategic update, Safe Money Report outlines a six-step framework for navigating financial instability during what Martin Weiss calls the “Age of Chaos.” With decades of historical data behind its Weiss Ratings system, the firm presents a non-promotional roadmap for evaluating liquidity, asset safety, inflation hedges, and emerging market trends in crypto and real estate. The release examines current economic conditions and how informed analysis, rather than emotion, can inform long-term wealth protection strategies.
In this 2025 strategic update, Safe Money Report outlines a six-step framework for navigating financial instability during what Martin Weiss calls the “Age of Chaos.” With decades of historical data behind its Weiss Ratings system, the firm presents a non-promotional roadmap for evaluating liquidity, asset safety, inflation hedges, and emerging market trends in crypto and real estate. The release examines current economic conditions and how informed analysis, rather than emotion, can inform long-term wealth protection strategies.
SYDNEY, July 3, 2025 /PRNewswire/ -- First AML, the leading end-to-end anti-money laundering (AML) compliance platform continues its rapid growth in Australia as Tranche...
Join our two-day seminar designed for pharmaceutical, biopharmaceutical, biologics, and medical device professionals to master FDA inspections. Gain hands-on strategies to efficiently prepare, conduct, and respond. Includes slides, certificates, Q&A, and inspection handouts. Optimize outcomes.
Join our two-day seminar designed for pharmaceutical, biopharmaceutical, biologics, and medical device professionals to master FDA inspections. Gain hands-on strategies to efficiently prepare, conduct, and respond. Includes slides, certificates, Q&A, and inspection handouts. Optimize outcomes.
Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored by ANZUP, and supported by Bayer and...
Emergency Nursing Triage Education Program boosts nurses' confidence in triage decisions
SCHAUMBURG, Ill., June 30, 2025 /PRNewswire/ -- When lives are on the line, every...
Lyophilization Process Innovation, Food Preservation Demand, and Pharmaceutical Industry Expansion Drive 7.9% CAGR Growth Across Global Markets
REDDING, Calif., June 27, 2025 /PRNewswire/ -- The...
Lyophilization Process Innovation, Food Preservation Demand, and Pharmaceutical Industry Expansion Drive 7.9% CAGR Growth Across Global Markets
REDDING, Calif., June 27, 2025 /PRNewswire/ -- The...
The imminent restructuring of the Federal Emergency Management Agency (FEMA) under the Trump administration could significantly alter disaster recovery dynamics for homeowners. This shift...
COPENHAGEN, Denmark, June 26, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of the first of two clinical trials designed to support approval and use of the MVA-BN® mpox/smallpox vaccine in vulnerable populations: infants under 2 years of age and pregnant and breastfeeding women